Home › Asset managers › Guggenheim › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Guggenheim voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,550 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Guggenheim voted | Funds |
|---|---|---|---|---|---|---|---|
| Rafael Holdings, Inc. | January 8, 2026 | Election of Directors: Michael J. Weiss | Director Elections | Board | AGAINST | 1 | |
| Rafael Holdings, Inc. | January 8, 2026 | To approve an amendment to the Rafael Holdings, Inc. 2021 Equity Incentive that will increase the number of shares of the Company's Class B common stock available for the grant of awards thereunder by 1,000,000. | Compensation | Board | AGAINST | 1 | |
| Rapid Micro Biosystems, Inc. | May 21, 2026 | To elect one Class II Director to serve until the 2029 Annual Meeting of Stockholders: Richard Kollender | Director Elections | Board | WITHHOLD | 1 | |
| Scilex Holding Company | December 11, 2025 | Proposal to approve the repricing of certain stock options issued under the Scilex Holding Company 2022 Equity Incentive Plan, as amended, that are held by eligible service providers of the Company (the "Option Repricing Proposal"); and | Compensation | Board | AGAINST | 1 | |
| Scilex Holding Company | June 24, 2026 | Election of Director: Dorman Followwill | Director Elections | Board | WITHHOLD | 1 | |
| Scilex Holding Company | June 24, 2026 | To approve the amendment to the Scilex Holding Company 2022 Equity Incentive Plan (as amended) to (i) increase the number of shares authorized for issuance thereunder by 1,300,000 shares to 2,765,789 shares and (ii) increase the number of shares authorized for issuance thereunder pursuant to the exercise of incentive stock options to 2,765,789 shares. | Compensation | Board | AGAINST | 1 | |
| Seer, Inc. | July 7, 2025 | Election of Directors: Dipchand (Deep) Nishar | Director Elections | Board | WITHHOLD | 1 | |
| Seer, Inc. | July 7, 2025 | Election of Directors: Nicolas Roelofs, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Seer, Inc. | July 7, 2025 | Election of Directors: Terrance McGuire | Director Elections | Board | WITHHOLD | 1 | |
| Sensei Biotherapeutics, Inc. | June 10, 2026 | To approve the 2026 Employee Stock Purchase Plan. | Compensation | Board | AGAINST | 1 | |
| Sensei Biotherapeutics, Inc. | June 10, 2026 | To approve the 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Sensei Biotherapeutics, Inc. | June 10, 2026 | To elect the Board's two nominees to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Bob Holmen | Director Elections | Board | WITHHOLD | 1 | |
| Senseonics Holdings, Inc. | May 20, 2026 | To elect the three nominees of the Board of Directors, to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Timothy T. Goodnow | Director Elections | Board | WITHHOLD | 1 | |
| Seres Therapeutics, Inc. | June 9, 2026 | Approval of an amendment and restatement of the Seres Therapeutics, Inc. 2025 Incentive Award Plan to increase the number of shares available for issuance under the plan. | Compensation | Board | AGAINST | 1 | |
| Seres Therapeutics, Inc. | June 9, 2026 | Election of Directors: Stephen A. Berenson | Director Elections | Board | WITHHOLD | 1 | |
| Smith Micro Software, Inc. | May 26, 2026 | Approval of an amendment to the Smith Micro Software, Inc. Amended and Restated Omnibus Equity Incentive Plan | Compensation | Board | AGAINST | 1 | |
| Solo Brands, Inc. | May 22, 2026 | Approval of the Solo Brands, Inc. Amended and Restated 2021 Incentive Award Plan. | Compensation | Board | AGAINST | 1 | |
| Solo Brands, Inc. | May 22, 2026 | Election of Directors: Paul Furer | Director Elections | Board | WITHHOLD | 1 | |
| Solo Brands, Inc. | May 22, 2026 | Election of Directors: Peter Laurinaitis | Director Elections | Board | WITHHOLD | 1 | |
| Spero Therapeutics, Inc. | June 23, 2026 | To approve adoption of the 2026 Spero Therapeutics, Inc. Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Star Holdings | May 21, 2026 | Election of Trustees: Clifford De Souza | Director Elections | Board | WITHHOLD | 1 | |
| Star Holdings | May 21, 2026 | Election of Trustees: Nina Matis | Director Elections | Board | WITHHOLD | 1 | |
| Star Holdings | May 21, 2026 | Election of Trustees: Richard Lieb | Director Elections | Board | WITHHOLD | 1 | |
| Tenaya Therapeutics, Inc. | May 27, 2026 | To amend and restate our 2021 Equity Incentive Plan to, among other things, increase the number of shares of our common stock reserved for issuance by approximately 3% of our outstanding shares and remove the annual limit of 4 million shares from the "evergreen" provision. | Compensation | Board | AGAINST | 1 | |
| Tenaya Therapeutics, Inc. | May 27, 2026 | To elect three Class II directors to hold office until our 2029 annual meeting of stockholders and until their respective successors are elected and qualified: Amy Burroughs, M.B.A. | Director Elections | Board | WITHHOLD | 1 | |
| The Cato Corporation | May 21, 2026 | ELECTION OF DIRECTORS: Bryan F. Kennedy | Director Elections | Board | WITHHOLD | 1 | |
| The Cato Corporation | May 21, 2026 | ELECTION OF DIRECTORS: Dr. Pamela L. Davies | Director Elections | Board | WITHHOLD | 1 | |
| The Cato Corporation | May 21, 2026 | ELECTION OF DIRECTORS: Thomas B. Henson | Director Elections | Board | WITHHOLD | 1 | |
| The Children's Place, Inc. | May 6, 2026 | Election of Directors: Kim Roy | Director Elections | Board | AGAINST | 1 | |
| The Children's Place, Inc. | May 6, 2026 | Election of Directors: Muhammad Asif Seemab | Director Elections | Board | AGAINST | 1 | |
| The Children's Place, Inc. | May 6, 2026 | Election of Directors: Muhammad Umair | Director Elections | Board | AGAINST | 1 | |
| The Children's Place, Inc. | May 6, 2026 | Election of Directors: Turki Saleh A. AlRajhi | Director Elections | Board | AGAINST | 1 | |
| The ONE Group Hospitality, Inc. | May 19, 2026 | Proposal to approve an amendment to the Company's 2019 Equity Incentive Plan to increase the number of shares issuable under the 2019 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Vera Bradley, Inc. | June 4, 2026 | To approve an amendment to the Company's 2020 Equity and Incentive Plan to increase the number of shares authorized for issuance by 3,000,000 shares. | Compensation | Board | AGAINST | 1 | |
| VirnetX Holding Corporation | June 11, 2026 | To approve an amendment to our Amended and Restated 2013 Equity Incentive Plan to increase the share reserve. | Compensation | Board | AGAINST | 1 | |
| Vor Biopharma Inc. | August 25, 2025 | To approve the amendment and restatement of the Company's Amended and Restated 2021 Equity Incentive Plan to, among other things, (i) increase the number of shares of the Company's common stock reserved for issuance thereunder by 25,000,000 shares and (ii) decrease the number of shares that will automatically be added to the share reserve thereunder on January 1 of each calendar year from five percent (5%) to four percent (4%) of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year through and including calendar year 2035. | Compensation | Board | AGAINST | 1 | |
| Vor Biopharma Inc. | June 11, 2026 | To approve the amendment and restatement of our Amended and Restated 2021 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Workhorse Group Inc. | June 29, 2026 | Approve the Amended and Restated Workhorse Group 2023 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Workhorse Group Inc. | June 29, 2026 | Election of Directors: Matthew O'Leary | Director Elections | Board | AGAINST | 1 | |
| Workhorse Group Inc. | June 29, 2026 | Election of Directors: Paul Savoie | Director Elections | Board | AGAINST | 1 | |
| XBiotech Inc. | August 29, 2025 | To approve the Company's 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| XPeng, Inc. | June 26, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 1 | |
| XPeng, Inc. | June 26, 2026 | Approve PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 1 | |
| XPeng, Inc. | June 26, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 | |
| Xilio Therapeutics, Inc. | November 21, 2025 | To approve a one-time repricing of certain outstanding employee stock options. | Compensation | Board | AGAINST | 1 | |
| Xilio Therapeutics, Inc. | November 21, 2025 | To approve the Xilio Therapeutics, Inc. 2025 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Xilio Therapeutics, Inc. | June 10, 2026 | To approve our Amended and Restated 2021 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Zentalis Pharmaceuticals, Inc. | June 16, 2026 | Election of each of the Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: David Johnson | Director Elections | Board | WITHHOLD | 1 | |
| a.k.a. Brands Holding Corp. | May 20, 2026 | Elect Class II directors to serve on the Board until the 2029 Annual Meeting and until their successors are duly elected and qualified: Wesley Bryett | Director Elections | Board | WITHHOLD | 1 | |
| comScore, Inc. | June 16, 2026 | The approval of an amendment to the Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of the company's common stock available for grant by 3,000,000 | Compensation | Board | AGAINST | 1 |
← Previous Page 26 of 26
← Back to Guggenheim 2025-2026 overview
Built November 1, 2026 from SEC Form N-PX filings.